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HORMONE EXCRETION DURING
THE NORMAL MENSTRUAL CYCLE.
INTRODUCTION.
There are many subjects in modern medicine con¬
cerning which much remains still to be discovered, and
few of these present a greater and more interesting
scope for investigation and speculation than do the
organs of the endocrine system and their internal
secretions, and of these, perhaps the most intriguing
are the female sex hormones.
In this last decade, a vast amount of research
work has been done on this subject of the female sex
hormones and the literature relating to it has become
immensely complex.
Although there are still many matters for con¬
jecture in female sex physiology, yet, as the result
of brilliant investigations in Britain, America, and
on the Continent, a rapid advance in knowledge has been
made, and more definite views concerning the source and
function of the ovarian and pituitary hormones have
been established.
In consequence of this, many phenomena of menstrua¬
tion, conception, pregnancy and parturition have been
more/
2.
more definitely elucidated and beneficial results
obtained with hormone therapy in the treatment of
obstetrical and gynaecological disorders.
Even better results could be obtained, however,
with hormone therapy, if it were not for the divergent
views still held on the phenomena of menstruation and
the relation to it of the autocoids of the ovary and
pituitary; and if unequivocal threshold values of the
hormonic content of the blood and urine could be com¬
puted in the normal menstrual cycle, and a similar,
almost routine, hormone analysis could be conducted in
abnormal cases, the rationale of treatment in these
cases could be placed on a more stable and scientific
basis and would do much to confound the "blind empiri¬
cism" and "hit or miss" principles ascribed to much of
the present hormone therapy.
Such were the principles in mind, when it was
decided to take as the subject of this thesis the study
of the phenomenon of the normal human menstrual cycle
and the relation to it of the sex hormones excreted
into the urine. - As an essential basis of this study,
at least a brief description of the normal menstrual
cycle is required.
3.
CHANGES IN THE ENDOMETRIUM
DURING THE NORMAL MENSTRUAL CYCLE.
The normal menstrual cycle is regarded as being
of twenty-eight days' duration, the first day of
bleeding being taken as the first day of the cycle.






The endometrium, throughout the cycle, is In a con¬
stant state of transition. According to the views
of Schrdderj1^ the endometrium is divisible into basal
and functional layers. The basal layer takes no part
in the monthly cyclical changes and serves only as a
source for the regeneration of the mucous membrane
after it has disintegrated during menstruation.
In the post-menstrual phase, immediately after
the/
Menstrual or destructive phase, which
lasts about five days.
Post-mentrual or reparative phase, which
occupies about five days.
Quiescent or resting phase, lasting
about five days.
Pre-menstrual, progestational or
constructive phase, which lasts
about fourteen days.
the period, a process of repair occurs in the endo¬
metrium, when the epithelium grows and replaces the
cast-off epithelium, and the glands are simple
straight tubes.
After the repair process is completed, the endo¬
metrial activity diminishes for about five days during
the quiescent phase, and then about the middle of the
cycle the endometrium resumes its activity and the
glands become lengthened and tortuous, and dilated
with secretion, and have a characteristic cork-screw
appearance. The endometrium is increased in thick¬
ness and is very similar to the decidua of early
pregnancy. This is the premenstrual or progestational
stage and continues for about fourteen days until the
onset of menstruation, when the superficial hyper-
trophied layers of the endometrium degenerate and are
expelled together with blood which is simultaneously




On the researches of Crew and Wiesner, ' and
others working at the University of Edinburgh, are
based many of the modern views concerning the menstrua
mechanism, which will be more fully discussed later.
That menstruation depends on the active function¬
ing of the ovary stimulating the uterus, has for long
been accepted. For, it begins at puberty, when
ovulation and maturation first occur in the ovaries,
and ends at the menopause, when this ovarian activity
ceases.
Furthermore, after the operation of bilateral
total oophorectomy and after X-ray and radium therapy
to the ovaries, an artificial menopause is induced.
This is usually accompanied, as at the normal change
of life, by atrophy of the genital tract and the
breasts, by symptoms of increased excitability of the
sympathetic nervous system and by lowered basal meta¬
bolism with frequently the development of secondary
masculine characteristics. The above mentioned facts
and the results obtained by castration, ablation and
transplantation experiments, and by those of injecting
ovarian, placental and urinary extracts, indicate that
blood-borne ovarian stimuli or internal secretions
induce/
induce the menstrual uterine changes, and that these
changes are without any direct control from, the central
nervous system. Indirectly, however, through the
action of the sympathetic nervous system causing a
hypersecretion of adrenaline, when over-stimulated, a
disharmony of ovarian function and upset of menstrua¬
tion probably results. This temporary upset of con¬
trol of menstruation is shown as is well known in
"newly married women, by the fear of pregnancy
in unmarried women who have exposed themselves to the
risk of it, and by the excessive desire for children
in married women who are both neurotic and barren".
(Johnstone)
Analogous to this inhibitory action of adrenaline
on ovarian activity, Robson^^ working on the lower
rodents, found that the administration of adrenaline
besides luteal extracts inhibited oestrus.
This exemplifies the fact, that the functions of
the glands of the endocrine system, as the thyroid,
suprarenals, pituitary and ovaries, etc., are all
intimately linked up with each other, and that hyper-
stimulation of one of them often upsets the harmonious
working of the others or, to put it briefly, the pro¬
ducts of the endocrine system are either synergistic
or/
7.
or antagonistic in action to each other, and in this
connection, as will later he discussed, the internal
secretions of the ovary and pituitary are closely
related.
The results of modern treatment for diabetes
mellitus and myxoedema with extracts from animal
pancreas and thyroid (insulin and thyroxin respective¬
ly) prove that the hormones from the endocrine glands
are not specific for species, race or sex and that the
sex hormones are interchangeable in action from species
to species and produce similar effects, e.g. extracts
of the anterior pituitary lobe and of its hormone
secretion obtained from the urine of the adult human
female, and implants of the gland from an animal such
as the ox, cause maturation of the ovaries of immature
rats and mice.
The view that the hormones act as catalytic
agents, which initiate chemical changes and themselves
remain unaffected thereby, is supported by the work of
(5)
Prank/ who found a large concentration of ovarian
hormone in the menstrual fluid, compared with that inj
the blood and thus, it would appear that the endo¬
metrium concentrates, but does not metabolise the
ovarian hormone. Before proceeding further, a brief
account/
8.
account of the ovary and the changes occurring in it
throughout the menstrual cycle, will be described, as
a knowledge of this is essential for understanding
the hormonal control of the genital tract.
CHANGES IN THE OVARY DURING THE NORMAL
MENSTRUAL CYCLE.
The ovary is divided into two regions - (1) the
Medulla and (2) the Cortex.
(1) The Medulla consists of unstriped muscular and
connective tissue, blood vessels, nerves and lymphatics
and is partly surrounded by the cortex.
(2) The Cortex is the important functioning part of
the ovary and has three main constituents:-
(a) Germinal Epithelium, which is a layer of
cuboidal epithelium covering the surface
of the ovary.
(b) Stroma, consisting of connective tissue
cells, throughout which are scattered
immature Graafian Follicles.
(c) The Graafian Follicles each contain a
potential ovum and are derived from the
germinal epithelium. It is reckoned
that, at birth, each ovary contains




At puberty, an immature Graafian Follicle or
Primordial Follicle containing the ovum, develops and
ripens, forming a mature Graafian Follicle which con¬
sists of an outer connective tissue covering - tunica
externa and tunica interna, over several layers of
cuboidal epithelial cells, called the membrana granu¬
losa, which forms a cavity containing the liquor
folliculi, and embedded in the membrana granulosa at a
point where its cells are heaped up into many layers,
called the discus proligerus, is the ovum.
The Graafian Follicle rapidly increases in size
and comes to the surface of the ovary and ruptures,
expelling the ovum surrounded by membrana granulosa
cells, called the corona radiata, and liquor folliculi
into the peritoneal cavity, where it reaches the mouth
; of the uterine tube and, if not fertilized in the
j uterine tube, it rapidly degenerates. One ovum,
rarely two ova, is extruded from the ovary at regular,
usually monthly, intervals from puberty to the
menopause.
The general opinion of modern observers is that
ovulation occurs from twelve to sixteen days after the
onset of the last menstrual period, and is usually
reckoned as occurring about the fourteenth day (Corner^
After/
10.
After rupture of the Graafian Follicle, the cells
of the theca interna and membrana granulosa lining the
walls of the follicle, assume a new structure, by
proliferation and vascularisation and a convoluted
yellow body, known as the corpeus liiteum, is produced
which fills up the cavity.
The corpus luteum, by this process, develops to
full maturity and increases In size for about a fort¬
night, when, if pregnancy has not supervened, retro¬
gressive changes take place, ■commencing about two days
before the onset of the next menstrual period. These
retrogressive changes result In the corpus luteum
becoming converted into a structureless hyaline body
known as the corpus albicans. A new Graafian Follicle
again assumes control and so the cycle continues.
This process results In the minimum of scar tissue
being formed in the ovary.
If pregnancy does occur, the mature corpus luteum
persists in that state for many weeks. It Is then
called the "corpus luteum of pregnancy" in contra¬
distinction to the "corpus luteum of menstruation"
above described. The ripening of the next Graafian
Follicle Is arrested until some time after the ter¬
mination of pregnancy, when It is still possible to
see/
11.
see the corpus luteum, but it is diminished in size
owing to similar degenerative changes as before having
occurred in it.
A double cycle of changes thus occurs in the
ovary - ripening of the Graafian Follicle terminating
in rupture, followed in turn by the formation of the
corpus luteum.
From the foregoing description of changes in the
ovary, one may surmise that it has two main function-
: ing parts - (1) the Graafian Follicle, and (2) the
Corpus Luteum - which are hormone secreting, and that
they are intimately concerned with the menstrual cycle.
The pioneer work on the study of the ovarian
(7)
hormones was done by Iscovescov in 1912, when he
found, by injecting immature female rabbits, that
aqueous glandular ovarian extracts were inactive, while
alcoholic or ethereal extracts, caused hyperplastic
changes in the genital tract and breast tissue to re¬
sult, and he found the same changes to occur when he
injected, placental extracts into the animals. The
usage of immature rabbits excluded the possibility of
corpus luteum tissue affecting the action of the ex¬
tracts, for ovulation in the rabbit is only evoked by
coitus or "jumping" and does not occur spontaneously.
Iscovesco/
12.
Iscovesco thus discovered the solvent of one of
the ovarian hormones or "female sex hormone" as it was
called.
In 1S15, Prank and Rosenbloom^similarly-
observed hyperplastic effects in the immature animal
treated with lipoid extracts of the placenta and
corpus luteum.
The above mentioned investigations on the imma¬
ture animal, in which extracts of the Graafian Fol¬
licle, corpeus luteum and placenta were used, imply
that a similar hormone is secreted by these three
structures, which is capable of producing hyperplastic
changes in the genital tract, typical of oestrus; and
this hormone has received the name of "oestrin" from
(9)
Parkes and Bellerby, which is more appropriate than
that of the female sex hormone or the various other
names given it as Alpha hormone, Theelin, Menformon,
Folliculin, etc. (The name "oestrone" will be used
for "oestrin" hereafter, in the text.)
To recapitulate, the hormone oestrone is secreted
by the ovary from the Graafian follicle, corpus luteum
and tissue stroma, and when injected into the immature
or oflphorectomised animal, produces specific changes
typical/
13.
typical of oestrus, as, hypertrophy of the uterus
including the endometrium and cornification of the
vagina. In addition, the placenta manufactures
oestrone of which large amounts are found in the urine
of pregnant women.
Using the immature monkey Macacus Rhesus,
Courrier, Kehl and Raynaud^were able "by injections
of oestrone to produce cornification of the vagina and
hypertrophy of the uterus involving both the muscle
and the endometrium; but, it was found, that the full
endometrial development, characteristic of the late
premenstrual stage, was never obtainable.
This ability of oestrone to produce nidatory
changes was demonstrated by Zondek/11^ who curetted
castrated women after prolonged oestrone medication,
when it was found that the endometrium, although
showing signs of proliferative.activity, yet did not
'
conform to that of the later premenstrual phase.
(12)
Werner and Collier curetted castrated women,
to whom had been administered large d-oses of oestrone
and they found that the endometrium was only charac-
teristic of the proliferative phase. They also
found, during treatment and after its cessation, that
vaginal bleeding occurred. This latter effect is
most/
14.
most probably due to the absence of the controlling
influence of the hormone progesterone from the corpus
luteum, which is to be discussed later.
Thus, oestrone is responsible for the production
of the proliferative phase of the endometrium in the
menstrual cycle, but it is unable to incite the
occurrence of the premenstrual or secretory phase.
Oestrone has several other important actions.
(13)Allen showed that the injection of large doses
of oestrone into immature monkeys produced harmful
.
effects on the gonads and inhibited ovulation.
Dahlberg^^^ was able to inhibit the gonadotropic
action of the urine of pregnant women by simultaneously
injecting the test animals with follicular fluid, and
he concluded that oestrone prevents maturation of the
ovum and ovulation, by antagonising the effect of the
anterior pituitary lobe hormone.
(15)
Zondek and Aschheim noted that large doses of
oestrone produced abortion regularly in mice during the
second half of pregnancy, but, when attempts were made
in the human female-to induce abortion and premature
labour with large doses of oestrone, as was done by
/ "l \
; Robinson, Datnow and Jeffcoate, ' their efforts were
met with almost complete failure. A further important
action/
15.
action of oestrone is that it is almost specific in
relieving the symptoms of upset which frequently occur
at the menopause or after bilateral o8phorectomy.
CHEMICAL CONSTITUTION OF OESTRONE.
Until now oestrone has been referred to as a
single substance, but recent work has shown that
several oestrone-like substances are obtainable from
the urine.
(17) - (IP)
Doisy and Butenandtv ' each were able to
isolate a crystalline oestrus-producing substance from
the urine, which has been named theelin ana is stated
to be a triple unsaturated oxyketone probably of the
stearin series with the formula of C-LgHggOg
(Ketohydroxyoestrin),
(19)
More recently Doisy and others isolated
another oestrus inducing substance similar to theelin,
with the formula of (Trihydroxy oestrin) and
called theelol or oestriol.
These workers have shown that the pure substance
Is lipoidal in character, being very soluble in methy¬
lated ether, alcohol, chloroform., acetone and benzol
and only slightly soluble in water. It is thermostable
for it is not destroyed by boiling.
16.
THE CORPUS LUTEUM HORMONE.
Perhaps the first person to direct attention to
the corpus luteum as being a gland, of internal secre¬
tion was Fraenkel^0^ who, as early as 1903, working j
with rabbits, found that removal of the corpus luteum
during early pregnancy, was followed, by abortion or
absorption of the foetus.
Thus, he established that the corpus luteum
hormone was necessary for the continuance of early
| pregnancy. If, however, the corpus luteum is removed
I
; late in pregnancy, it has been found that abortion
does not occur and this is explained by the assumption
that the placenta later takes over the functions of the
!
corpus luteum.
Fraenkel further showed that menstruation occurred
prematurely after removal of the ovary containing the
corpus luteum and also after excision of the corpus
luteum itself. This gave fouhdation to the concep¬
tion that menstruation is associated with the retro-
I I
I gression of the corpus luteum at the end of the
menstrual cycle, and with the removal from the circu-
| lation of its hormone.
(21)
Corner and Allen, who gave this luteal hormone




progesterone), observed in 1929, while working with
the immature rabbit, that the injection of a luteal
! extract promoted, but not consistently, the develop¬
ment of the endometrium to the late premenstrual or
progestational state.
(22)
Hisaw and Leonard " found, if injected with
oestrone for some time before the administration of
progesterone, that the immature animal developed the
progestational type of endometrium.
(23)
Allen, working on the mature oophorectomised
animal observed, that the injection of luteal extracts
had no effect on the endometrium, unless sufficient
; oestrone had been administered.
Thus, by itself, progesterone has no stimulating
effect on the endometrium, but when it is previously
sensitised by oestrone, progesterone carries on the
proliferative phenomena to those of the pregravid
state.
That this relationship applies to the human sub-
j ject, has been recently demonstrated by Kaufmann/2^
I He had as a patient a twenty-one year old girl who had
been castrated five years previously on account of
'
dermoid cysts in both ovaries, and whose uterus was in
I an atrophic condition. He administered to her for
about/
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about a month, a million international units of
oestrone and thirty-five rabbit units of progesterone
The endometrium developed enormously, to the pre¬
menstrual stage, as confirmed by examining a portion
of the endometrium curetted. Menstruation did not
occur. He repeated the experiment and found that
menstruation commenced two days after the last injec¬
tion of corpus luteum extract.
He was thus able for the first time to reproduce
exactly the normal menstrual cycle in the castrated
woman.
This experiment demonstrates conclusively that
oestrone and progesterone are the only hormones
required to produce full functional development of
the endometrium.
The luteal hormone, besides its influence on the
endometrium, also exerts control over the uterine
(?5)
musculature. Hisaw' was the first to demonstrate
the inhibitory effect of progesterone on uterine
contractions, and Knaus^®^ further showed that injec
tion of the hormone into the extirpated rabbit uterus
in vitro, caused inhibition of the reaction of the
muscle to pituitrin.
It is well known in the human subject, that the
uterine/
19.
uterine muscle is relatively insensitive to the action
of pituitrin during pregnancy and until a short time
before parturition.
Knaus's work therefore suggests that the onset
of labour at the end of pregnancy may be due to the
; uterine muscle recovering its power of response to the
posterior pituitary hormone, which till then had been
dominated by the corpus luteum hormone.
Progesterone has other important activities. It
has been found in the lower rodents, that large and
continued dosage of progesterone inhibits maturation
of the ovarian follicles and ovulation, and leads to
the suppression of oestrus. This was demonstrated
(27) fPRl
by Parkes and Bellerby and later by Patel,
I ■ I
when they injected luteal preparations into the lower
rodents.
Another power, which has been attributed to the
'
corpus luteum, is that of relaxation of the pelvic
ligaments of the guinea-pig, which usually occurs
later in pregnancy and at parturition (Fevold, Hisaw
& Mayer ) .
CHEMICAL CONSTITUTION OF PROGESTERONE.
Unlike oestrone, progesterone has not yet been
obtained in pure form and is thus not readily
available/
20.
available commercially. It is soluble in water, but
insoluble in lipoid solvents. It is destroyed at a
temperature of 50°C.
THE PITUITARY HORMONES.
In brief, the pituitary gland is a small oval-
shaped gland, attached to the floor of the third
ventricle of the brain and situated in the sella
'





The anterior lobe consists mainly of epithelial
cells, which are of three types: ■
(a) The Chromophobe or chief cells, which
remain clear when the tissue is
stained.
(b) The Chromophil cells, which stain
deeply and comprise (1) Basophilic
and (2) Acidophilic cells.
: Evidence favours the view that each of these three
varieties of cells has different functions.
The chromophobe cells of the anterior pituitary
increase/
21.
Increase In size and number during pregnancy and,
occasionally, to such an extent that due to pressure
on the optic tract hexnianopia is caused. This has
been shown by Erdheim and Stuirmie^30^ in the human and
(31)
by Cushing in the pregnant animal.
! 70\
Cushing and Davidoff,v 0n the other hand, have
shown that the acidophilic cells are chiefly concerned
with growth and the production of the hormone con¬
nected therewith. They found at autopsy in cases of
acromegaly in which invariably genital hypoplasia is
present, that adenomatous or hyperplastic changes of
the acidophilic cells of the pituitary existed, and
was usually accompanied by changes of an adenomatous
nature in the other endocrine glands.
It would appear, therefore, that derangement of
the anterior pituitary upsets the function of the
endocrine system more generally than does the mal¬
function of one of its other glands. Thus it might
be said that the pituitary gland exerts a controlling
force on the endocrine mechanism.
It has been shown'that periodicity and rhythm
prevail in the uterus throughout the normal sexual
cycle, and the question arises - Is there a mechanism




In 1901, Frdhlich/33' drew attention to there
heing a relationship between the pituitary gland and
the ovary, when he described his famous syndrome of
hypophyseal deficiency, later called Dystrophia
Adiposo-genitalis. This condition is characterised
by abnormal deposition of fat on the lower abdomen,
hips, upper thighs and breasts and sometimes hirsutism
of an almost masculine nature and amenorrhoea. The
disorder is thought to be due to atrophy of the
chromophobe or chief cells of the anterior lobe of
the pituitary, for autopsy sometimes reveals an adenoma
affecting these cells.
In addition to clinical observations as above
mentioned, the present knowledge of the anterior
pituitary lobe function was obtained by removal and
implantation experiments on animals, and also by feed¬
ing and injecting them with extracts of the gland.
In 1916 Goetsch^34^ showed that Immature rats fed
on anterior pituitary substance grew more rapidly, and
more quickly attained complete sexual development.
He also found that posterior pituitary feeding failed
to produce similar phenomena.
Numerous unsuccessful attempts at experimental




was evolved. Smith. demonstrated that removal of
the pituitary from rats was followed by ovarian atrophy
and total suppression of oestrus, but that these
phenomena could be prevented and the oestrus cycle
re-established by grafts of the anterior pituitary
lobe tissue into the hypophysectomised animals.
It was also found that pituitary implants and
extract injections into the oftphorectomised animal
produced no effect whatsoever on the genital tract.
(35)
Thus Smith was the first to establish the
fact that the follicular maturation process in the
ovary and the secretion of the hormone responsible
for oestrus are both dependent on the presence of the
pituitary gland, and its hormone secretion.
/ ry r* \
Smith and Engle further showed that implan¬
tation of anterior pituitary tissue into immature
female mice was, in addition to follicular maturation
and secretion of oestrone, also foliwed by ovulation.
(37)
Another investigator, Evans,v ' working with
alkaline extracts of the pituitary, obtained by
_N_
grinding up pituitary glands with 10 caustic soda,
and which were administered by injection into mature
rats for several days, demonstrated an inhibition of
oestrus. On examining the ovaries of these animals
when/
24.
when killed, he found an extensive luteinization of
the ovaries had occurred, without the formation of
mature Graafian follicles, which had heen apparently-
converted into corpora lutea. Evans had thus heen
able, by the use of an alkaline extract of the pituitary,
to cause luteinization of the Graafian follicles and
secretion of the corpus luteum hormone, progesterone.
(38)
Wiesner and Grew, working with the aLkaline
extract of the pituitary, removed from it the growth
factor by precipitating the protein with 20% sulpho-
salicylic acid and subsequent neutralization with
sodium bicarbonate, and they thus obtained a luteiniz¬
ing principle, free from the growth hormone, whose
presence in the alkaline extract previously used had
been causing some confusion in interpreting the results
of other workers. With this extract Wiesner and Crew
'demonstrated luteinization of the mouse ovaries with a
transformation of the vaginal epithelium into a state
analogous to the progestational or nidatory phase of
the endometrium, due to the influence of the corpus
luteum hormone Progesterone, and they term this state
that of "mucification". They maintain that this
extract is purely Pyogenic, i.e. capable of producing
progesterone alone through its action on the ovary,
and/
25.
and furthermore that this mucification reaction repre¬
sents a test for the luteinizing hormone. This has
not been substantiated and is not accepted as previous
work butHisaw^has shown that the progestational
effect in the animal thus treated is incomplete with¬
out the administration of a balanced quantity of
oestrone in addition to progesterone. The contention
is, therefore, that the product employed by Wiesner
and Crew incites the production of oestrone as well as
progesterone and that it has not a specific action as
was claimed in stimulating the production of proges¬
terone from the ovary, for the latter has no effect
without the preparatory action of the former.
From the foregoing experimental evidence, one may
conclude that the pituitary is capable of bringing
about two main reactions in the ovary:
(1) Follicular maturation, ovulation and the
secretion of oestrone, i.e., oestrogenic
reaction.
(2) Luteal tissue formation and the secretion of
progesterone, i.e., luteinizing or
kyo-genic reaction.
These two main reactions in the ovary have been
brought about by two kinds of pituitary preparation,




Bellerbyf by a series of experiments, claimed
that the oestrogenic factor could be obtained in acid
media, and that the luteinizing factor could be iso¬
lated from alkaline media, but no such conclusion is
justifiable in view of subsequent work.
These two different effects produced gave rise to
the theory, formulated by Wiesner and Crew, that two
gonadotropic hormones are produced by the anterior
pituitary lobe controlling ovarian function, and they
described these hormones as the Rho factors - Rho I
being responsible for the oestrogenic reaction and
secretion of the Alpha hormone or oestrone, whereas
Rho II was assumed to incite the luteinizing reaction
and secretion of the Beta hormone or progesterone.
Because of the divergent nature of the results occur¬
ring after injection with various extracts, they
assume that these hormones occur in varying propor¬
tions and that both their relative concentration and
absolute qixantity determine the effect produced.
(41)
On different grounds, Zondek and Ascheim also
postulated the existence of two gonadotropic hormones.
They discovered that during pregnancy in the human
'
subject an excess of anterior pituitary hormone is
excreted in the urine as the result of the hypertrophy
of/
27.
of the pituitary gland, which normally occurs at that
time. This discovery is the basis of the famous
Aschheim-Zondek pregnancy diagnosis test. These
workers, using immature mice which they injected with
urinary gonadotropic preparations, observed certain
characteristic reactions in the ovaries which they
divided into three main groups :
(1) The ovary showed follicular maturation,
ovulation and oestrone was secreted.
(2) In addition to the above effects, the ovary
was hyperaemic and showed blood spots.
(3) Luteinization of the ovary and formation of
corpora lutea atretica.
They applied the term, Prolan, to the gonadotropic
factors present in and recoverable from the urine,
and from the duality of the results obtained, i.e.,
(1) and (3) more particularly, they also presumed the
existence of two gonadotropic hormones, of which the
first, Prolan A, caused follicular maturation with
secretion of oestrone, and the second, Prolan B, in¬
cited luteinization followed by the secretion of the
corpus luteum hormone.
Prolan A and Prolan B are thus similar to the
Rho I and Rho II factors respectively of Wiesner and
Crew.
These/
Micro-photograph of section of Mouse Ovary
showing maturing Graafian follicles.
27B.
Microphotograph of section of ovary of a mouse
which had previously been treated with a
gonadotropic hormone urine preparation,
showing marked lutein!zation.
These gonadotropic hormones are said to "be
excreted together in the urine in varying proportions
and that in certain conditions the urine may contain
a preponderance of the one hormone, e.g. Zondek states
that the urine of gravid women yields only the
luteinizing principle (Prolan B or Rho II) because
the oestrogenic principle (Prolan A, Rho I) becomes
inert very rapidly, even on standing.
From the findings that small doses of urine pre¬
parations prove oestrogenic, whilst large doses induce
the second ovarian phase or luteinizing reaction, a
simple hypothesis suggests itself, that there is only
one gonadotropic hormone manufactured by the anterior
pituitary and that the reactions produced by it depend
on its degree of potency, and this theory receives
some support from other workers, e.g. Mazer and
(42)Goldstein. Much of the evidence, however, used
to support the respective views as to whether the
pituitary has one or two gonadotropic hormones is
inadequate, but on the whole, at present the weight
of evidence inclines towards the existence of two
gonadotropic hormones. The nature of these hormones
is still unknown and even their separate identity is






CHEMICAL PROPERTIES OF PROLAN.
1. Soluble in water.
2. Insoluble in ether and other lipoid solvents.
3. Precipitated by ethyl alcohol but not preci¬
pitated by sulphosalxcylic acid.
4. Not heat stable, destroyed at temperature
above 70°C.
5. Destroyed by strong acids and alkalis.
■
I
6. Molecule at least as big as that of Congo red.
METHOD ADOPTED FOR URINARY OBSTRONE EXTRACTION.
1. The total 24-hours output of urine, less
60 ccs. for the gonadotropic hormone estimation, to
which has been added 30 ccs. of 10$ HgSO^ per 270 ccs
of urine, is hydrolysed for eight hours under a reflux
condenser. This liberates the oestrone from its
organic combination in the urine. Oestrone is
thermostable and survives unimpaired boiling-point
temperature, as is produced in this process of hydro-
.
lysis.







to 250-300 ccs. by heating it in a fume chamber, in a'
porcelain basin under a constant stream of compressed
! air which reduces the boiling point of the evaporating
urine. The concentrated urine is thereafter placed
in the extraction tube under a reflux condenser.
Its level is brought to just below that of the
branch tube with distilled water washings from porce-
j lain basin, which leads to a flask containing methy¬
lated ether, in which oestrone is soluble, and set on
I a water bath heated by an electric plate, because of
.
the inflammable nature of the flask's contents.
;
Vaporised ether passes from the flask into the extrac¬
tion tube, reaches the condenser, where it is con-
.
densed and drops down on to the concentrated urine
and then flows back to the flask, thus maintaining a
constant circulation of the ether through the urine.
This process is allowed to continue for 24 hours,
after which the flask with its contents and any super-
natant ether from the extractor is removed.
N.B. After cleansing the extraction tube
before further use, the extraction
tube is thoroughly rinsed with
absolute alcohol (an oestrone solvent)
to prevent contamination of subsequent
extractions.
The next procedure is to drive off the ether




evaporate off from the flask, which Is placed, on the
water-hath until the volume of the ethereal extract
is sufficiently small to allow of its transference to
a small wide-necked "bottle, when the extract is
brought to a state of dryness by further evaporating
off the ether on the water-bath or by blowing it off
under a current of compressed air.
More methylated ether is added to the dry extract,
and the whole is agitated with a glass rod, and the
supernatant ether poured into another bottle through
a filter paper to prevent any of the dark coloured
debris from the extract being carried into the other
bottle, as it was found that these proved highly
toxic to the mice after injection.
To the other bottle, 8 ccs. of olive oil are
added and the ether is removed as before, when the
final oestrone extract has been prepared.
METHOD ADOPTED FOR BLOOD OESTRONE EXTRACTION.
To 45 ccs. of blood In a mortar, anhydrous sodium
sulphate is added In small amounts and the mixture
pounded with a pestle, until a fine dry powder is
obtained. The powder is then enclosed in fine dry
filter paper, into the form of a cylinder and placed
in the cylindrical container of a Soxhlet Tube
apparatus, which is connected above to a reflux con¬
denser and below to a flask, almost filled with methy¬
lated ether, and set on an electric water-bath and
extraction allowed to take place for 24-36 hours.
Vaporized ether passtes from the flask up an
external tube to the main Soxhlet Tube, where it im¬
pinges on the reflux condenser, is condensed and drops
down on to the blood, and sodium sulphate mixture en¬
closed in the filter paper, and percolates through it
to gradually accumulate till its level rises to the
upper limit of the syphon pipe of the apparatus, when
the whole ethereal content of the Soxhlet is syphoned
back into the flask and the process resumed. After
: extraction has occurred for 24 to 36 hours, allithe





and almost all evaporated off, and the remainder trans¬
ferred to a small wide-necked "bottle, in which It Is
then evaporated off to dryness.
The deposit is stirred up with a little more
ether, 1 cc. of olive oil added to it, and the residual
ether evaporated, off when the "blood oestrone extract,
ready for injection, has been prepared. This
technique is that described by Frank and has been
modified for our own use.
METHOD ADOPTED FOR GONADOTROPIC HORMONE
PREPARATION.
Sixty ccs. of urine are filtered, and to it are
added 240 ccs. of absolute alcohol, and the whole
amount is centrifuged in an electric centrifuge at
the rate of 3,000 revolutions per minute for ten
minutes. The supernatant fluid is discarded and the
precipitate is washed well with ether, to remove the
oestrone which is soluble in ether but in which the




To this residue is added 7 ccs. of distilled
water and the solution is neutralised by sodium bi¬
carbonate if acid, or by sulphosalicylic acid if
alkaline. Neutrality of the solution is indicated
by the appearance of a deep buff colour with "Universa
Indicator". This aqueous solution, in which the
gonadotropic hormone is soluble, is now ready for use.
(This technique is that of Zondek's Precipitation
Method modified for our own use.^^h
THE SEX •CYCLE OF THE MOUSE.
The sex cycle of the mouse will now be considered
as this was the only experimental animal used in the
course of this investigation, because it has proved
such a useful medium in the assay of the sex hormones
and. furthermore, because an understanding of its sexua
cycle has greatly elucidated that of the human cycle.
Stockard and Papanicolaou^45^ in 1917, first
described the specific oestrous changes occurring in the
uterine and vaginal epithelium of the guinea pig.
They/
35.
They were able to determine the state of the vaginal
epithelium at various stages in the oestrous cycle by
their method of taking vaginal smears from the animal.
This they did by introducing a wire loop into the
vagina and removing from it some of its desquamated
cellular content, which was spread on a glass slide,
stained and examined microscopically.
(46)Allen later described the changes taking
place during the oestrous cycle in the mouse.
In this species the female will only mate at
certain periods, namely, when in heat or during oestrus.
Oestrus usually occurs every four to six days and lasts
for one or two days. In the interval between oestrus,
termed di-oestrus, the animal does not mate. Oestrus
is accompanied by typical changes in the uterus,
vagina and ovaries. The oestrous cycle, like the
human menstrual cycle, may be divided into four
phases:
(1) Resting Phase or 'Di-oestrus .
The ovaries and uterus are small and the vaginal
mucosa consists of only several layers of nucleated
epithelial cells. The vaginal smear shows an abun¬











Vaginal smear from mouse in Resting or Di-oestrus
phase, showing numerous leucocytes and a few
nucleated epithelial cells.
(Stained methylene "blue.)
Vaginal smear from mouse in Constructive phase or
Pro-oestrus, showing many nucleated epithelial
cells and some leucocytes.
(Stained methylene blue.)
36.
(2} Pro-oestrus or Constructive Phase.
The ovaries are somewhat increased, in size and
contain maturing Graafian follicles. The uterus
becomes vascular, enlarged and distended with secretion.
The vaginal mucosa shows a marked multiplication of
its epithelial cell layers and the vaginal smear con¬
sists of nucleated epithelial cells and only a few
leucocytes (see Diagram).
(3) Oestrus or Heat is the stage of ovulation and
mating. The ovaries are increased, in size and show
matured Graafian follicles. The uterus is markedly
increased in size, and is distended with secretion.
The vaginal epithelial cells are very numerous and
the surface layers become cornified and shed large
non-nucleated epithelial cells which are demonstrable
in the vaginal smear (see Diagram).
(4) Post-oestrus.
At this stage corpora lutea replace the ruptured
Graafian follicles, but the endometrial changes do
not proceed to the progestational or mucification
stage, unless progesterone or the anterior pituitary
luteinizing hormone is administered, or unless mating
takes place. In the absence of mating, retrogressive
changes/
36A.
Vaginal smear from mouse during Oestrus or heat,
showing cells which are all large non-nucleated
squamous cells and represents full cornification,
e.g. C .
Microscopic section during Oestrus of mouse uterus
which is greatly increased in size, showing endo
metrial cells distended with secretion and the
surface layers becoming cornified.
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changes occur in the uterus and the vagina and the
cellular composition of the vaginal smear returns to
that of the di-oestrous phase.
Long and Evans (47) an{^ Allen(48) glowed that the
changes above outlined in the mouse in the oestrous
cycle, cease to occur after bilateral oophorectomy,
(49)
but in 1923 Allen and Doisy succeeded in reproduc¬
ing artificially the phenomena of the oestrous cycle
in spayed mice by the injection of a. lipoid extract
of follicular fluid.
This discovery has become the basis of the test
for the ovarian hormone, oestrone, and as such has been
used for that purpose in this work.
This test, then, of Allen and Doisy, is based on
the fact that the injection of immature or castrated
female mice with an active oestrone preparation brings
about in 72 to 96 hours the typical vaginal changes,
indicative of oestrus and demonstrable by vaginal
smearing.
38.
PREPARATION OF MICE FOR ASSAY OF OESTROiE.
For the assay of oestrone, on any moderate scale,
a large supply of castrated female mice is essential.
Mature, young, healthy, adult mice were selected
for bilateral oQphorectomy. This operation was per¬
formed under ether anaesthesia. The animal selected
for castration is placed on its abdomen, head-first
into the mouth of a tube of appropriate diameter and
at the bottom of which is a piece of cotton wool
saturated with ether.
When fully anaesthetised, as is indicated by the
rump and hind legs of the animal sagging, a transverse
incision is made through the skin on the dorsum, which
has been previously cleansed withjalcohol. The in¬
cision is made about a centimetre's distance superior
to the pelvic girdle and the skin flaps retracted.
Each ovary, and as much of the- peri-ovular fatty
tissue as possible, is removed through a small incision
made in the overlying muscles, using the peritoneal
fold running from the ovary to the kidney region as a
guide. The ovary is found in an antero-inferior
position to the lower pole of the kidney. The muscle
wounds are left unstitched and the skin edges are
brought/
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brought into apposition with a few stitches of linen
thread. This operation can be completed in five
minutes and with a mortality of about two per cent.,
when the operator becomes proficient.
After a few days, the o8phorectomized mice are
smeared daily for eight days to exclude the possibility
of a remnant of ovarian tissue making unreliable,
subsequent oestrone assays. A persistent negative
smear indicated by the presence of leucocytes and
occasional nucleated epithelial cells substantiates
that all the ovarian tissue has been removed. About
three weeks after an oestrone assay with a batch of
</\ I
mice, it was the practice to take smears daily from
each mouse for about eight days, in order to be
absolutely certain that no regeneration of ovarian
tissue had occurred to upset the results, as in a few
rare instances this was recognized from the vaginal
smear showing a positive result of cornified non-
nucleated epithelial cells.
40.
STANDARDIZATION OF THE HORMONES.
This is most conveniently done in relation to
the mouse.
The Standardization of Oestrone is performed on
mature oftphorectomized mice and is estimated in mouse
units.
In all cases thus investigated, standardization
was performed hy the injection of four doses at twelve-
hourly intervals, in the course of thirty-six hours
and the mouse unit was taken as that amount of oestrone
which would produce full vaginal cornification in fifty
per cent, of the animals injected.
According to Deanesley and Parkesf®^ the absorp¬
tion of oestrone from an oily basis is said to be very
slow, as appreciable amounts of it remain vinabsorbed
several days after injection, and divided injections
in an aqueous medium are suggested as being more
suitable, for their effectsjcan be compared with those
given by an international standard.
The Gonadotropic Hormone Standardization is
performed on immature mice and is estimated in mouse
units.
Each mouse receives one injection at twelve-hourly
intervals/
41.
intervals, until six such doses have been adminis¬
tered. About one hundred hours after the first
injection, the animal is killed and the state of the
ovaries assessed. The minimum amount which brings
about a definite effect in at least one ovary is termed
the unit of the substance.
This test has to be performed on several animals
as there is often a slight variation in the reaction,
from ovary to ovary in individxial animals.
TECHNIQUE OF ASSAY OF OESTRONE.
As the twenty-four hours urine oestrone extract
contains an unknown quantity of oestrone, its estima¬
tion is done by one of assay or trial and error.
As a preliminary., to indicate the potency of the
oestrone extract being estimated, three mice are used,
and each is injected with .2 cc. of the extract twice
daily for two days, and smeared thereafter twice daily
on the third, fourth and fifth days. If the smears,
on examination microscopically on a slide stained with
methylene/
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methylene blue, are positive, as is shown by full
cornification in more than half the number of mice,
five mice are taken and injected with .1 cc. of the
extract, twice daily for two days, and smeared on the
subsequent three days, twice daily.
If these smears prove positive, five more mice
are employed and injected with .05 cc. of the extract
as before. If these smears prove negative the result
lies between the doses of .1 cc. and .05 cc.
If, however, the injection of .1 cc. as before
had given negative smears, a further five mice with
the dosage of .15 cc. would have been used and if this
gave positive smears the result would lie between the
doses of .15 cc. and .1 cc., e.g. -
(1) 3 mice with .2 cc. gave positive smears.
(2) 5 mice " .1 cc. " positive "
(3) 5 mice " .05 cc. " negative "
. . result lies between .1 cc. and .05 cc.
If, however, (2) 5 mice with .1 cc. gave negative
smears
(4) 5 mice with .15 cc. gave positive
smears
. . result lies between .15 cc. and .1 cc.
The estimation of the potency of the urine oestrone
extract in mouse units can be performed quite simply.
As/
43.
As will be remembered, the total twenty-four
hour oestrone content of the urine was contained in a
basis of 8 ccs. of olive oil.
. . in (1) where .2 cc. was the dose, each mouse
received .8 cc. of the extract, which gave a
positive result
, 8 ccs.
. . each mouse received A = more than 10
mouse units
of oestrone.
In (2), where .1 cc. was the dose, each mouse received
.4 cc. of the extract, which gave a positive result
. . each mouse received = more than 20
mouse units of
oestrone.
In (3) where .05 cc. was the dose, each mouse received
.2 cc. of the extract, which gave a negative result




. . The potency of the extract is between more
than 20 and less than 40 mouse units.
In (4) similarly, where .15 cc. was the dose, each
mouse received .6 cc. of the extract, which gave a
positive result
• Sees




. . The potency of the extract would lie between
more/
44.
more than 13 mouse units and less than 20
mouse units.
By a process of dilution of the extract and
gradation of the dosage, still more accurate results
are obtainable but sometimes minor catastrophes occur
red, as the extract proving toxic to the mice, upset
complete estimation.
The number of o8phorectomized mice used for the
assay of each extract varied in amount up to about
twenty mice and this too, at first, varied according
to the stock of unused mice, and mice previously used
and when ready for injection.
One had to regularly prepare fresh mice by
oophorectomy, as some of the test animals- succumbed
owing to the extracts proving toxic, or to kill off
many of the animals owing to their having developed
sloughing sores on the back, at the site of injection
For the purpose of injecting the extracts, tuber
culin syringes were used which had long needles (l|r
inches long).
The animal was gripped by the nape of the neck
and tail and the extract injected through the loose
skin at the back of the neck into the tissue
immediately underlying the skin.
Blood/
45.
Blood oestrone assay was carried out as for
urinary oestrone estimation, except that only one
mouse was used for each assay, as the oestrone content
of 40 ccs. of blood in the cases examined was small.
TECHNIQUE OF ESTIMATION OF GONADOTROPIC
HORMONE.
Healthy, immature, female mice about three weeks
old were used for this purpose. For each extract,
three mice are employed. Each mouse receives by
injection .3 cc. twice daily for three days, and, about
one hundred hours after the first injection, are
killed and the genital tract examined for macroscopic
changes, and the ovaries removed, preserved in 5 per
cent, formalin to be later serially sectioned and
examined under the microscope for signs of follicular




It is now an accepted fact that oestrone is ex¬
creted in the urine and faeces by the human female
throughout the period of sexual activity.
The excretion of oestrone in the urine "begins at
puberty, when menstruation is first initiated, for
oestrone is not demonstrable in the urine before then
and is continued until some time after the menopause.
There are varying amounts of the hormone excreted,
corresponding to the hormone content of the blood and
the various phases of the menstrual cycle.
If pregnancy supervenes there is a marked increas
in the hormone excretion as was shown by Zondek and
Aschheim.
There are several factors which affect hormone
excretion.
It has already been mentioned that the hormones
function as catalysts, which are unaffected by any
action that they initiate, but more recent work by
(52)
Robson, MacGregor et alia, indicates that the meta¬
bolism of the body can destroy or render inactive an
; appreciable amount of the oestrous hormone.
(53)
Siebke and Shuschania have shown that the
total/
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total daily excretion of oestrone is more or less
equally divided between the urine and faeces, i.e.
fifty per cent, eliminated by each route.
Thus, appreciably less than fifty per cent, of
the total oestrone produced, is excreted in the urine
and faeces .
During the menstrual cycle, oestrone is continu¬
ously excreted in the urine. Frank^5^ has shown
that there is an increase in the amount excreted occur
ring about the middle of the cycle, about the time of
ovulation, and towards the end of the cycle, a few
days before the onset of menstruation.
(55)
Siebke found that the maximum oestrone
excretion occurred about nine days before the onset of
(56)
the next period. Zondek found that the oestrone
in the urine was about 10 mouse units per litre during
the intermenstrual period and about 20-30 mouse units
. per litre during the premenstrual phase.
The presence of the corpus luteum hormone is not
demonstrable in the urine.
The gonadotropic hormones are excreted throughout
the greater part of the life cycle and are present in
the urine before puberty. Zondek states that during
the menstrual cycle only the follicular maturation
hormone/
48.
hormone, Prolan A, is excreted and that its excretion
is increased during the premenstrual phase.
During pregnancy, however, he showed that there
is a very marked increase in the excretion of the
gonadotropic hormone.
HORMONE ANALYSIS OP CASES INVESTIGATED.
This investigation was undertaken in order to
establish normal values for the amounts of oestrone
and gonadotropic hormone excreted at the various
phases of the menstrual cycle.
The urines examined were obtained from healthy
women, of whom five were nulliparous and one parous,
who menstruated normally and who had regular twenty-
eight day menstrual cycles.
A twenty-four hours output of urine was obtained
from each woman at weekly intervals, so as to coincide
with the main phases of the menstrual cycle.
The estimation of the total hormone excretion,
each/
49.
each day throughout the menstrual cycle, was found
Impracticable, partly owing to the enormous amount of
work entailed and to the fact that the women were
engaged in active work daily which would, have upset
their convenience, and it was considered that reliable
specimens at weekly intervals would be of more value
than quantitative estimations of doubtful daily
urinary output.
The age period of cases investigated was between
twenty-four and forty-three years, and is fairly com¬
prehensive of the average duration of sexual activity.
50
Miss A.
Age - 43 years.
Menarche' - 14-|- years.
4
Menstruation - regular.
















A1 25:8:35 8 1640 ccs. 27-40 0
A2 1:9:35 15 1000 ccs. < 10 0





290 ccs. < 40 -
51.
A 1.
25.8.35 24-hour Specimen of Urine = 1640 ccs.
Urine Oestrone 24-hour Output.





10.10.35 Smears Read: C (3).
Result: More than 10 m.u. per 24 hours.





14.10.35 Smears Read: C (5).
Result: More than 20 m.u. per 24 hours.





24.10.35 Smears Read: C ^ (2); C (3).
Result: Less than 40 m.u. per 24 hours.
(4) Total Extract 8 cc. 5 mice. Total Dose .15 cc
M. E.
31.10.35 .1
1.11.35 .05 .1 (r\
2.11.35 .05
\i\ ,U-
4.11.35 Smears read: C (4); C ■g (1).
Result: Less than 27 m.u. per 24 hours.
URINE QESTRONE: 27-40 m.u. per 24 hours.
52.
A 1.
Urine Gonadotropic Hormone, 25.8.55 (8th day).






4.9.35 All dead, but no effect uteri or ovaries
Microscopic Examination of
Ovaries showed no signs of
follicular activity (0).
A 2.
1.9.35 24-hour Output of Urine = 1000 ccs.
Urine Oestrone 24-hour Output.





10.10.35 Smears Read: C.-j (3).
Result: Less than 10 m.u. per 24 hours





15.10.35 Smears read: Leucocytes mainly - few
nucleated cells.
Result: Less than 10 m.u. per 24 hours
URINE OESTRONE: Less than 10 m.u. per 24 hours.
53.
A.2.
Urine Gonadotropic Hormone, 1.9.55 (15th day).







Very slight enlargement uterus.
Nil ovaries. Only one survived.
Microscopic Examination of Ovaries
showed no signs of follicular
activity (0).
8.9.35 24-hour Output of Urine = 1,260 ccs.'
Urine Oestrone 24-hour Output.






10.10.35 Smears read: 6 ^ (2).








15.10.35 Smears read: Leucocytes mainly.














24.10.35 Smears read: Leucocytes mainly - few
cornlfied cells.
Result: Less than 13 m.u. per 24- hours
URINE QESTRQNE: 10-13 m.u. per 24 hours.
A 3,
Urine Gonadotropic Hormone 8.9.55 (25rd day).







Slight enlargement of uterus.
Nil ovaries.
Two dead.
Microscopic Examination of Ovaries showed
slight signs of follicular activity (+)
A 4.
12.9.35 Urine collected 24 hours before onset of
period which came on unexpectedly and
so is not the full 24-hour Output - 290 ccs
Urine Oestrone.







14.10.55 Smears read: Negative, leucocytes mainly.
Result: Less than 10 m.u. per 24 hours
in 290 ccs.
Assuming that this is only a
fourth of the total average
output, the oestrone content
of 24-hours specimen would be
less than 40 m.u. per 24 hours.
A 4.
Urine Gonadotropic Hormone 12.9.35 (28th day).







Uteri and ovaries negative.
Microscopic Examination of Ovaries:




Gon.H rm.-----(0)v-H-) OesianneinMouseUnits10,234 .
57.
Miss B.
Age - 33 years.
Menarche' - 18 years.
6
Menstruation - 27 regular.
















B1 11:9:35 7 1700 ccs. < 13 0
B2 17:9:35 13 1350 ccs. I 13 0
B3 24:9:35 20 1560 ccs. 13-16 0
B4 1:10:35 27 1660 ccs. < is 0
58,
B 1.
11.9.35 24-hour Output of Urine = l,700ccs.
Urine Oestrone 24-hour Output.




31.10.35 Smears read: C (2); C (3).
Result: Less than 13 m.u. per 24 hours
B 1.
Urine Gonadotropic Hormone 11.9.35.
60 ccs . Urine . 3 mice. Dose .5 cc .
M. E.
16.9.35 .3




No effect uteri or ovaries.
Microscopic Examination of Ovaries
showed no signs of follicular
activity (0}.
B 2.
17.9.35 24-hour Output of Urine = 1,350 ccs.
Urine Oestrone 24-hour Output.




30.10.35 Smears read: C -j (5) .
Result: Less than 13 m.u. per 24 hours
59.
B 2.
Urine Gonadotropic Hormone 17.9.55.







No effect uteri or ovaries.
Microscopic Examination of Ovaries
showed no signs of follicular
activity (0).
B 5.
24.9.35 24-hour Output of Urine = 1,560 ccs.
Urine Oestrone 24-hour Output.




31.10.35 Smears read: C ^ (3); C (2).
Result: More than 13 m.u. per 24 hours.





8.11.35 Smears read: C | (1); C ~ (l) .
Result: Less than 16 m.u. per 24 hours.
(3)/
60.














(2); C 1 (2)
4 4 "4
Result: Less than 20 m.u. per 24 hours.














Result: Less than 16 m.u. per 24 hours.
URINE 0ESTR0NE: 13-16 m.u. per 24 hours.
B 5.
Urine Gonadotropic Hormone 24.9.55.















No effect uteri or ovaries.
Microscopic Examination of Ovaries





1.10.35 24-hour Output of Urine = 1,660 ccs.
Urine Oestrone 24-hour Output.




31.10.35 Smears read: C | (2); C | (1); C ~ (2)
Result: Less than 13 m.u. per 24 hours.





4.11.35 Smears read: C ~ (5).
Result: Less than 20 m.u. per 24 hours.




3.11.35 Smears read: C —^(5).
Result: Less than 22 m.u. per 24 hours.
URINE QESTROUE: Less than 13 m.u. per 24 hours.
B 4.
Urine Gonadotropic Hormone 1.10.55.









No effect uteri or ovaries.
Microscopic Examination of Ovaries



































Age - 24 years.




















C1 3:12:35 8 1610 ccs. 10-20 0
C2 7:12:35 12 990 ccs. COV 0
C3 15:12:35 19 1265 ccs. < 10 +"
C4 23:12:35 26 1290 ccs. >40
65.
C 1.
3.12.35 24-hour Output of Urine = 1,610 ccs
Urine Oestrone 24-hour Output.





25.1.36 Smears read: Leucocytes mainly.
Result: Less than 20 m.u. per 24 hours.




26.3.36 Smears read: C ~ (2) .
Result: More than 10 m.u. per 24 hours.




30.3.36 Smears read: G ^ (1); C (2); C ^ (2).
Result: Less than 20 m.u. per 24 hours.
URINE QESTRONE: 10-20 m.u. per 24 hours.
C 1.
.
Urine Gonadotropic Hormone 5.12.55 (8th day).
ccs. Urine/
66.






No effect uteri or ovaries.
Microscopic Examination of Ovaries
showed no signs of follicular
activity (0).
C 2.
7.12.35 24-hour Output of Urine = 990 ccs.
Urine Oestrone 24-hour Output.





30.1.36 Smears read: C -j (2); C -y (2): 1 dead.
Result: Less than 10 m.u. per 24 hours.




25.3.36 Smears read: C (l) ; C y (2).
Result: Less than 10 m.u. per 24 hours.




30.3.36 Smears read: C — (4).
Result: Less than 8 m.u. per 24 hours.
URINE QESTR0NE: Less than 8 m.u. per 24 hours.
67.
C 2.
Urine Gonadotropic Hormone 7.12.55 (12th day).







Wo effect uteri or ovaries.
Microscopic Examination of Ovaries
showed no signs of follicular
activity (0).
G 5.
15.12.35 24—hour Output of Urine = 1,265 ccs.










12.4.36 Smears read: c \ (2) .
Result: Less than 10 m.u. per 24- hours.





20.4.36 Smears read: C | (1); C M (2); C I (l)
vfc 4c
Result: Less than 10 m.u. per 24 hours.
URIWE QBSTRONE: Less than 10 m.u. per 24 hours.
68.
C 5.
Urine Gonadotropic Hormone 15.12.55 (19th day) ■_






Two mice died 17.1.36 (uteri and
ovaries unaffected).
18.1.36 One mouse killed.
Wo effect uterus or ovaries.
Microscopic Examination of Ovaries
showed slight signs of follicular
activity (+-) .
C 4,
23.12.35 24-hour Output of Urine = 1,290 ccs.
Urine Oestrone 24-hour Output.





23.3.36 Smears read: C ^ (3).
Result: More than 10 m.u. per 24 hours




25.3.36 Smears read: C -J; (3).
Result: More than 10 m.u. per 24 hours
(3)/
69.




27.3.36 Smears read: C (4); C (l) .
Result: More than 20 m.u. per 24 hours.






Result: More than 40 m.u. per 24 hours.
2.4.36 Smears read: C ~ (5).





9.4.36 Smears read: C ^ (5)
.
Result: More than 7.5 m.u.
= more than 80 m.u. In 24 hours
in 8 ccs. 100% solution.
URINE 0BSTRQNE: More than 80.m.u. per 24 hours.
Urine Gonadotropic Hormone 23.12.35 (26th day).






No effect uteri or ovaries.
Microscopic Examination of Ovaries







Age - 35 years.
Menarche - 13 years.
Menstruation - slightly irregular.













per 24- Hrs .
Gonadotropic
Hormone
D1 6:11:35 28 620 ccs. 27-40
D2 14:11:35 7 730 ccs. 20-40 0
D3 21:11:35 14 1000 ccs. < 8 4"
D4 29:11:35 21 1060 ccs. 10-13
72.
D 1 •
6.11.35 24-hour Output of Urine = 620 ccs.
(24 hours before period.)
Urine Oestrone 24—hour Output.





6.1.36 Smears read: C — (3).
Result: More than 10 m.u. per 24 hours.




9.1.36 Smears read: C (4).
Result: More than 20 m.u. per 24 hours.




18.1.36 Smears read: C J; (1);
Leucocytes mainly (4).
Result: Less than 40 m.u. per 24 hours.





25.1.36 Smears read: C ^ (4-); C — (1).
Result: More than 27 m.u. per 24 hours.
(5)/
73.





28.1.36 Smears read: C \ (1); C (4).
Result: Less than 40 m.u. per 24 hours
URINE 0ESTR0NE: 27-40 m.u. per 24-hour Output.
D 2.
14.11.35 24—hour Output of Urine - 730 ccs.
Urine Oestrone 24-hour Output.





25.3.36 Smears read: C (3)
Result: More than 10 m.u. per 24 hours





30.3.36 Smears read: C ^ (4).
Result: More than 20 m.u. per 24 hours








22.4.36 Smears read: C 4 (1); C 4 (2); C 4 (2)
Result; Less than 40 m.u. per 24 hours
URINE OBSTRONE; 20-40 m.u. per 24-hour Output.
D 2.
Urine Gonadotropic Hormone 14.11.55 (7th day).






30.11.35 Two mice dead, one dying.
Slight enlargement of uterus.
Microscopic Examination of Ovaries
showed no signs of follicular
activity (0).
D 5.
21.11.35 24—hour Output of Urine = 1,000 ccs.
Urine Oestrone 24-hour Output.





25.3.36 Smears read: C 4, Leucocytes mainly (3J
Result: Less than 10 m.u. per 24 hours.
(2)/
75.




30.3.36 Smears read: C (3); C \ (1).
Result: Less than 8 m.u. per 24 hours.
URINE 0ESTR0NE: Less than 8 m.u. per 24 hours.
D 3.
Urine Gonadotropic Hormone 21.11.35 (14th day}.






No effect uteri or ovaries.
Microscopic Examination of Ovaries
showed slight signs of follicular
activity (+).
D 4.
29.11.35 24-hour Output of Urine = 1,060 ccs.
Urine Oestrone 24-hour Output.




25.3.36 Smears read: C (2); C ^ (l).
Result: More than 10 m.u. per 24 hours.
(2)/
76.




30.3.36 Smears read: C (4); C (1)
Result: Less than 20 m.u. per 24 hours.





22.4.36 Smears read: C j (l) ; C (1); C ^ (1).
Result; Less than 13 m.u. per 24 hours.
URINE 0ESTR0NE: 10-13 m.u. per 24-hour Outpiit.
D 4.
Urine Gonadotropic Hormone 29.11.55 (21st day)





14.12.35 All mice found dead.





























































24631024682 DAYOPCYCLE. Gon.Horm-----(0)++-V-) OestroneinMousUnits-10,234 .
78.
Miss E.
Age - 25 years.
Menarche' - 12 years.
Menstruation - ■— regular.
















E1 6:11:35 2 1350 ccs. 10-20 0
E2 14:11:35 10 1320 ccs. C,10 "T"
E3 20:11:35 16 1065 ccs. > 20 -V*
E4 26:11:35 22 1400 ccs. 20-40
79,
El.
6.11.35 24-hour Output of Urine = 1,350 ccs.
Urine Oestrone 24-hour Output.
(1) Total Extract 8 ccs. 5 mice. Dose .2 cc .
M. E.
25.1.35 .2
26 .1.36 .2 .2
27.1.36 .2
30.1.36 Smears read: C (5)
Result: More than 10 m.u. per 24 hours.





25.1.36 Smears read: Leucocytes mainly (5)
Result: Less than 20 m.u. per 24 hours.
URINE OESTRONE: 10-20 m.u. per 24 hours.
E 1.
Urine Gonadotropic Hormone 6,11.55 (2nd day).





All mice died after second injection (0).
80..
E 2.
14.11.35 24-hour Output of Urine = 1,320 ccs.
Urine Oestrone 24-hour Output.






23.3.36 Smears read: C (1); leucocytes mainly (2)
Result: Less than 10 m.u. per 24 hours.





22.4.36 Smears read: C ^ (1); C (1) ;
leucocytes mainly (3)
Result: Less than 10 m.u. per 24 hours.
URINE 0ESTRONE: Less than 10 m.u. per 24 hours.
E 2.
Urine Gonadotropic Hormone 14.11.35 (10th day).







No effect uteri or ovaries.
Microscopic Examination of Ovaries




20.11.35 24-hour Output of Urine = 1,065 ccs.
Urine Oestrone 24-hour Oixtput.








25.3.36 Smears read: C ^ (2)
Result; More than 10 m.u. per 24 hours







30.3.36 Smears read: C (3); C f (2).
Result: More than 20 m.u. per 24 hours








■ 22.4.36 Smears read: C -1 (4).
Result: More than 13 m.u. per 24 hours
URINE OESTRONE: More than 20 m.u. per 24 hours.
E 5.
Urine Gonadotropic Hormone 20.11.35 (16th day).












Minute blood spots in ovaries.
Uteri enlarged.
Microscopic Examination of Ovaries
showed definite signs of follicular
activity (+■+) .
Used mice were inadvertently made use
of in this test, which is therefore
of no value.
E 4.
26.11.35 24-hour Output of Urine = 1,400 ccs.
Urine Oestrone 24-hour Output.




27.3.36 Smears read: C | (3); C | (2).
Result: More than 20 m.u. per 24 hours.





23.3.36 Smears read: C ^ (2)
Result: More than 10 m.u. per 24 hours.




4 , . 0 , ,
2.4.36 Smears read: C 4 (1); C 4 (4) leucocytes
nucleated and non-nucleated
epithelial cells.
Result: Less than 40 m.u. per 24 hours.
(4)/
83.




9.4.36 Smears read: C •§ (2); C (2)
Result: Less than 40 m.u. per 24 hours.
URINE 0ESTR0NE: 20-40 m.u. per 24 hour Output.
E 4.
Urine Gonadotropic Hormone 26.11.55 (22nd day).
60 ccs. Urine. 5 mice . Dose .5 cc.







Uteri and ovaries unaffected.
Microscopic Examination of Ovaries




Don.H rm.---(0,+,etc.) OestrineinMouseUnits10,23 ,4 tc.
85.
Mrs F.
Age - 38 years. Para I.
Menarcher - 12 years.
3-4
Menstruation - — -- regular.
















F1 20:1:35 24 680 ccs. 13-20
F2 27:1:35 3 1460 ccs. 13-20 0
P
7) 3:2:35 10 1090 < x° 0
F4 10:2:35 17 1180 13-20 0
86.
F 1.
20.1.35 24-hour Output of Urine = 680 ccs.
Urine Qestrone 24-hour Output.




7.3.35 Smears read: C (2); G — (1).
Result: More than 13 m.u. per 24 hours.




24.3.35 Smears read: c| (3); C | (2).
Result: More than 20 m.u. per 24 hours.





19.11.35 Smears read: C -j (2); C -j (1).
Result; More than 13 m.u. per 24 hours.
URINE QESTRQNE: 13 to more than 20 m.u. per 24 hours
F 1.
Urine Gonadotropic Hormone 20.1.55 (24th day).








No effect uteri or ovaries.
Microscopic Examination of Ovaries
showed slight evidence of follicular
activity (-1") .
F 5.
27.1.35 24-hour Output of Urine = 1.460 ccs.
Urine Qestrone 24-hour Output.




24.3.35 Smears read: leucocytes mainly (5).
Result: Less than 20 m.u. per 24 hours.






19.11.35 Smears read: C 4(2); C 2 (!)•
Result: More than 13 m.u. per 24 hours






3.12.35 Smears read: (1 mouse dead); C 4 (2).
Result: Less than 13 m.u. per 24 hours




Urine Gonadotropic Hormone 27.1.35.







One uterus slightly enlarged.
Microscopic Examination of Ovaries
showed no signs of follicular
activity (0).
F 3.
3.2.35 24-hour Output of Urine = 1,090 ccs.
Urine Oestrone 24-hour Output.





24.3.35 Smears read: Leucocytes mainly.
Result: Less than 20 m.u. per 24 hours.







Smears read: C (3)
Result: Less than 13 m.u. per 24 hours
(3)/
89.





3.12.35 Smears read: C (3).
Result: Less than 10 m.u. per 24 hours
URINE OESTRQNE: Less than 10 m.u. per 24 hours.
F 5.
Blood Oestrone 5.2.35 4-0 ccs. Venous Blood.





3.4.35 Smears read: C ^ (1).
Result: Less than 1.25 m.u. per 24- hours
F 3.
Urine Gonadotropic Hormone 5.2.55.















One uterus greatly enlarged: two
slightly enlarged.
Microscopic Examination of Ovaries





10.2.35 24-hour Output of Urine 1,180 ccs.
Urine Oestrone 24-hour Output.





25.3.35 Smears read: C 4 Leu.cocytes mainly.
Result: Less than 20 m.u. per 24 hours.





19.11.35 Smears read: C -j (2); Leucocytes
mainly (1).
Result: More than 13 m.u. per 24 hours





2.12.35 Smears read: C ^ (2); C (1).
Result: More than 13 m.u. per 24- hours




Blood Oestrone 10.2.55 50 ccs. Venous Blood.




5.3.35 Smears read: C ~ (1).
Result: Less than 1.25m.u. oer litre.
F 4.
Urine Gonadotropic Hormone 10.2.55.






1.3.35 All died after last injection.
No effect uteri or ovaries.
Microscopic Examination of Ovaries




Son.H rm.-----(0,+, OestrineinMouseU ts--(10,2340).
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COMMENTARY ON RESULTS OF HORMONE ANALYSIS.
A. OESTRONE.
A survey of the graphic representations of the
; urinary oestrone excretion values, at the various
stages of the cycle in all the cases Investigated,
| shows curves, which, for the most part, are of a
similar nature, except perhaps in one instance, Miss
B., where there is very little variation in the
oestrone excreted throughout the cycle.
The graphs show relatively highoestrone values in
| the post-menstrual phase, which decline fairly rapidly
as the quiescent phase is reached, and then increase
in value during the pre-menstrual phase, tip to the
time of menstruation.
A study of the table of approximate mean values
brings out these findings more clearly. In this
table the approximate means of the oestrone excretion
values for each seven days of the menstrual cycle have
been assessed and graphically represented. This
table brings out, even more clearly, the decline in
the amount of oestrone excreted in the post-menstrual
phase to its minimum, in or about the time of





increase, which occurs in the premenstrual phase, up
to the onset of menstruation, when there evidently is
a diminution in excretion.
One may therefore, not unreasonably, pretend that
. " .
the ovary in the post-menstrual phase secretes a
■
sufficient amount of oestrone for the regeneration and
'
I repair, of the endometrium, after the destructive phase
'
jof menstruation has taken place, whereupon the endo¬
metrium passes into the resting or quiescent stage
and consequently, as much oestrone as was previously
produced is not required.
When the post-menstrual period is reached, an
increased amount of oestrone is secreted and this is
'accompanied by the secretion of Progesterone in order
to build up the endometrium into a more perfect struc¬
ture for the possible reception of a fertilized ovum
If this contingency, hov/ever, does not occur,
then the hormone production activity of the ovary of
oestrone and Progesterone diminishes temporarily.
The approximate mean values of oestrone excretion
in (1) the post-menstrual period was found to be 18 m.u
per 24- hours; (2) in the quiescent stage to be 12 rn.u.
per 24 hours, and (3) in the post-menstrual stage to




It was not found practicable to estimate the
amounts of gonadotropic hormone excreted, owing to
these being rather small in the quantities of urine
tested.
A glance at the Table representing the gonado¬
tropic excretion values shows apparently very low
excretion values of the gonadotropic hormone in the
post-menstrual phase and in part of the quiescent stag
of the menstrual cycle, and also that the values in¬
crease in amount in the premenstrual phase.
In all cases investigated no signs of follicular
maturation or luteinization or blood spots were
observed in the ovaries with the naked eye, and only
evidence of follicular maturation was seen under the
microscope, which agrees with the view held by
C 5 6 ^
Zondek, ' that only the follicular maturation hormone:
is excreted in the urine during the menstrual cycle
and he gives the following values for the various
stages of the cycle;
Post-menstrual Phase - 8 rat units per day.
Quiescent Phase - 25 " " " "
Pre-menstrual Phase - 29 " " " "
Menstrual Phase - 25 " " "
and./























nosignsoffoll cularactivity, slight"11" definite"»
96.
and these values are, according to Zondek, only the
effect of the follicular maturation hormone of the
pituitary - Prolan A.
Thus, with regard to the cyclic changes in the
endometrium, one might state that the pituitary
hormone output, in the early stages of the cycle,
namely the post-menstrual and early quiescent period.s ,
lis relatively low, and that, thereafter, increases in
amount until the onset of menstruation, and that
|throughout, it exerts in a consistent manner, an in¬
creasingly stimulative effect on the ovary, causing
that organ in turn to secrete the hormones, Yrtiich
.provoke the various cyclic changes of the endometrium,
until, about the onset of menstruation when its
activity temporarily diminishes, which then causes the




To recapitulate, the at present accepted theory
jconcerning the mechanism controlling the menstrual
cycle is, that it is governed by the anterior lobe,
which/
97.
which probably produces two hormones: (1) Prolan A,
which stimulates follicular maturation in the ovary,
■and the secretion of oestrone, which in turn causes
the endometrium to develop to the post-menstrual phase,
and. (2) Prolan B, which causes the formation of the
corpus luteum and the secretion of Progesterone, which
advances the development of the endometrium to that of
the pre-menstrual phase.
|
The pituitary then might be termed the conductor
of the instruments of the menstrual orchestra, directing
.
its harmony, but, from what score must the conductor
beat the tempo? What music is to be played?
In plainer terms, is there a higher nervous sexual
centre, which controls the hormone function of the
ipituitary?
(57)
Hohlweg and Junkmann "" have suggested by their
experiments on castrated rats, into which implants of
hypophyseal tissue have been made, that the pituitary
is controlled extrinsically by fine nerve connections
to the brain via the pituitary stalk.
(58)Theobald ° has recently put forward an hypo¬
thesis from evidence of a clinical nature, which
'
jpostulates that there are one or more centres in the
brain, probably in the hypothalmic region, which
regulate/
98.
regulate the functions of the reproductive tract,
through afferent and efferent neuro-hormonic stimuli.
He considers the efferent route to be composed by:
(1) The hormones of the anterior lobe, and
(2) Nervous impulses to the generative organs;
and the afferent pathway to be composed of:
(1) The hormones of the ovary.
(2) Impulses transmitted from the external
generative organ.
(3) Impulses transmitted from the higher
special centres.
*
This hypothesis is rather novel and attractive,
yet it requires the corroboration of more fundamental
s tudy.
It, however, causes a swing of the pendulum in
the opposite direction, in focussing the attention
of investigators of this subject, to a higher centre
or centres, which may be the final link in the chain
whereby the phenomena of menstruation, ovulation,




It is with great pleasure that I acknowledge the
help that I received in this work, firstly from Dr T
N. MacGregor, who initiated me into the technique for
sex hormone investigation, and to Professor F. A. E.
Crevir for the opportunity to work at the Department
of Animal Genetics, University of Edinburgh.
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